X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Sun Pharma Advanced Research Company Ltd.
BSE CODE: 532872   |   NSE CODE: SPARC   |   ISIN CODE : INE232I01014   |   22-Nov-2024 Hrs IST
BSE NSE
Rs. 204.40
14 ( 7.35% )
 
Prev Close ( Rs.)
190.40
Open ( Rs.)
192.80
 
High ( Rs.)
209.75
Low ( Rs.)
190.45
 
Volume
138629
Week Avg.Volume
46354
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 204.50
14.17 ( 7.44% )
 
Prev Close ( Rs.)
190.33
Open ( Rs.)
192.00
 
High ( Rs.)
209.70
Low ( Rs.)
190.54
 
Volume
5043926
Week Avg.Volume
1103940
 
52 WK High-Low Range(Rs.)
189.75
472.8
Particulars Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operational & Financial Ratios          
   Earnings Per Share (Rs)-11.96  -6.86  -7.48  -5.77  -11.92  
   CEPS(Rs)-11.59  -6.50  -7.11  -5.35  -11.56  
   DPS(Rs)0.00  0.00  0.00  0.00  0.00  
   Book NAV/Share(Rs)3.85  15.80  -7.47  -6.42  -0.71  
   Tax Rate(%)0.00  0.00  0.00  0.00  0.00  
Margin Ratios          
   Core EBITDA Margin(%)-534.50  -89.65  -136.07  -53.36  -403.58  
   EBIT Margin(%)-511.55  -90.02  -138.48  -55.54  -403.22  
   Pre Tax Margin(%)-513.74  -93.22  -148.19  -59.75  -406.70  
   PAT Margin (%)-513.74  -93.22  -148.19  -59.75  -406.70  
   Cash Profit Margin (%)-497.68  -88.29  -140.79  -55.43  -394.36  
Performance Ratios          
   ROA(%)-58.96  -40.10  -79.80  -60.18  -93.11  
   ROE(%)-121.73  -143.72  0.00  0.00  -225.08  
   ROCE(%)-112.88  -69.44  -225.57  -254.10  -178.95  
   Asset Turnover(x)0.11  0.43  0.54  1.01  0.23  
   Sales/Fixed Asset(x)0.51  1.71  1.07  1.96  0.71  
   Working Capital/Sales(x)29.99  0.87  -1.37  -1.46  -0.46  
Efficiency Ratios          
   Fixed Capital/Sales(x)1.97  0.58  0.93  0.51  1.40  
   Receivable days116.55  46.20  60.25  24.26  62.28  
   Inventory Days0.00  0.00  0.00  0.00  0.00  
   Payable days0  0  0  0  0  
Valuation Parameters          
   PER(x)0.00  0.00  0.00  0.00  0.00  
   PCE(x)-31.93  -27.62  -41.77  -26.48  -8.35  
   Price/Book(x)96.16  11.36  -39.75  -22.07  -135.68  
   Yield(%)0.00  0.00  0.00  0.00  0.00  
   EV/Net Sales(x)157.49  23.92  59.34  15.55  33.79  
   EV/Core EBITDA(x)-31.79  -28.11  -45.27  -30.37  -8.64  
   EV/EBIT(x)-30.79  -26.57  -42.85  -28.01  -8.38  
   EV/CE(x)69.23  11.14  29.08  17.13  9.52  
   M Cap / Sales158.92  24.39  58.81  14.68  32.92  
Growth Ratio          
   Net Sales Growth(%)-68.36  73.98  -45.74  229.31  -57.99  
   Core EBITDA Growth(%)-84.23  -12.94  -38.85  56.85  -117.91  
   EBIT Growth(%)-79.79  -13.09  -35.29  54.64  -113.11  
   PAT Growth(%)-74.36  -9.43  -34.58  51.62  -114.81  
   EPS Growth(%)-74.37  8.32  -29.71  51.62  -114.81  
Financial Stability Ratios          
   Total Debt/Equity(x)0.38  0.00  -0.37  -1.37  -3.59  
   Current Ratio(x)1.01  2.54  0.42  0.26  0.29  
   Quick Ratio(x)1.01  2.54  0.42  0.26  0.29  
   Interest Cover(x)-233.48  -28.15  -14.26  -13.19  -115.79  
   Total Debt/Mcap(x)0.00  0.00  0.01  0.06  0.03